[Effect of pyrrolidine dithiocarbamate on retarding denervated skeletal muscular atrophy].
Słowa kluczowe
Abstrakcyjny
OBJECTIVE
To investigate the preventive and therapeutic effects and the mechanisms of pyrrolidine dithiocarbamate (PDTC) on the atrophy of denervated skeletal muscle.
METHODS
Thirty adult Wistar rats of either gender, weighing (200 +/- 10) g were randomly divided into 3 groups: group A (n=6, control group), group B (n=12, denervation group), and group C (n=12, PDTC treatment group). The sciatic nerves of the rats were only exposed without cutting off in group A, and the rats were made denervated gastrocnemius models in groups B and C. PDTC of 100 mg/(kg x d) was injected peritoneally in group C and an intraperitoneal injection of the same amount normal saline was given in group B. After 14 and 28 days, the gastrocnemius was harvested to measure the ratio of muscle wet weight; the levels of nuclear factor of kappaB (NF-kappaB) p65 protein and the opening of the mitochondrial permeability transition pore (MPTP) in the gastrocnemius were detected respectively by Western blot and laser confocal scanning microscope; and the apoptotic cells in atrophic muscle were measured with TUNEL.
RESULTS
The ratio of muscle wet weight in group A was 1.039 +/- 0.115, and it significantly decreased in groups B and C (P < 0.05); after 14 and 28 days of operation, the ratio of muscle wet weight in group C significantly increased when compared with those in group B (P < 0.05). The expression of NF-kappaB p65 protein in group A was 0.224 +/- 0.041; the expressions of NF-kappaB p65 in groups B and C significantly increased when compared with that in group A (P < 0.05); however, the expression of NF-kappaB p65 in group C was significantly lower than that in group B (P < 0.05). The MPTP fluorescence intensity in group A was 31.582 +/- 1.754; the MPTP fluorescence intensity was significantly lower in groups B and C than in group A (P < 0.05), and the MPTP fluorescence intensity in group C was significantly higher than that in group B (P < 0.05). The rate of apoptosis in group A was 4.542% +/- 0.722%; after 14 and 28 days of operation, the rates of apoptosis significantly increased when compared groups B and C with group A, and significantly decreased when compared group C with group B (P < 0.05).
CONCLUSIONS
PDTC can retard denervated skeletal muscle atrophy, and the effect may have a relationship with its inhibition on NF-kappaB, the opening of the MPTP, and the ratio of apoptosis.
